Search results
Wegovy will 'bankrupt the health care system,' says Sen. Sanders in new report
BenefitsPRO· 1 day agoThe committee launched an investigation into Novo's pricing — including roughly $1,350 a month for...
Is Eli Lilly's Latest Deal a Gamechanger?
The Motley Fool via AOL· 3 days agoMoreover, early research is showing that GLP-1 treatments have applications outside of diabetes and obesity care. For example, earlier this year the <...
FTC Continues to ‘Dispute’ Orange Book Device Patent Listings, But Still No Antitrust Enforcement |...
JD Supra· 2 days agoMost recently, on April 30, 2024, the FTC initiated a second round of patent listing disputes – this one targeting more than 300 device patent listings for 20 medicines approved to treat < ...
Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade
InvestorPlace· 1 day agoFor example, inventors of technology developed with federal funding retain rights to the patents....
Earnings call: Humacyte anticipates strong market entry post-FDA review By Investing.com
Investing.com· 4 days agoThe U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application...
Health Benefits of Magnesium Taurate
Health via Yahoo News· 4 days agoHow To Take Magnesium Taurate Magnesium taurate isn’t regulated by the U.S. Food and Drug Administration (FDA). It ...
Wegovy users keep weight off for nearly four years: Study
The Hill via AOL· 3 days agoNewly released clinical trial data on the GLP-1 agonist drug Wegovy found that weight loss was...
Lilly's Once-Weekly Insulin Top-Line Results Show Benefit
Medscape· 2 days agoEli Lilly has announced positive phase 3 topline results for its once-weekly insulin efsitora alfa...
FTC targets 300 Big Pharma 'junk patents,' sends warning letters to top drugmakers
BenefitsPRO· 2 days agoThe agency sent letters to 10 companies, warning that their patent listings were invalid. It also...
FDA targets health inequality by improving at-home devices
MedTech Dive via Yahoo Finance· 4 days agoMichelle Tarver, an FDA official, said a new program is meant to advance health equity by...
